These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 24098950)
21. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744 [TBL] [Abstract][Full Text] [Related]
22. 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours. von Guggenberg E; Dietrich H; Skvortsova I; Gabriel M; Virgolini IJ; Decristoforo C Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1209-18. PubMed ID: 17308920 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of 99mTc-peptide-ZHER2:342 Affibody® molecule for in vivo molecular imaging. Zhang JM; Zhao XM; Wang SJ; Ren XC; Wang N; Han JY; Jia LZ Br J Radiol; 2014 Jan; 87(1033):20130484. PubMed ID: 24273251 [TBL] [Abstract][Full Text] [Related]
25. Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids. Surfraz MB; King R; Mather SJ; Biagini S; Blower PJ J Inorg Biochem; 2009 Jul; 103(7):971-7. PubMed ID: 19447500 [TBL] [Abstract][Full Text] [Related]
26. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins. Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868 [TBL] [Abstract][Full Text] [Related]
27. Preclinical Evaluation of Oroujeni M; Rinne SS; Vorobyeva A; Loftenius A; Feldwisch J; Jonasson P; Chernov V; Orlova A; Frejd FY; Tolmachev V Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803361 [TBL] [Abstract][Full Text] [Related]
28. 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule. Engfeldt T; Tran T; Orlova A; Widström C; Feldwisch J; Abrahmsen L; Wennborg A; Karlström AE; Tolmachev V Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1843-53. PubMed ID: 17565496 [TBL] [Abstract][Full Text] [Related]
29. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]
30. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides. Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030 [TBL] [Abstract][Full Text] [Related]
31. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands. Liu S; Edwards DS; Looby RJ; Harris AR; Poirier MJ; Barrett JA; Heminway SJ; Carroll TR Bioconjug Chem; 1996; 7(1):63-71. PubMed ID: 8741992 [TBL] [Abstract][Full Text] [Related]
32. Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence. Engfeldt T; Orlova A; Tran T; Bruskin A; Widström C; Karlström AE; Tolmachev V Eur J Nucl Med Mol Imaging; 2007 May; 34(5):722-733. PubMed ID: 17146656 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, radiolabeling and evaluation of [ Dinmohammadi F; Erfani M; Shamsaei M; Shirmardi SP; Goudarzi M Bioorg Chem; 2023 Jan; 130():106237. PubMed ID: 36402025 [TBL] [Abstract][Full Text] [Related]
35. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands. Liu S; Edwards DS; Harris AR Bioconjug Chem; 1998; 9(5):583-95. PubMed ID: 9736492 [TBL] [Abstract][Full Text] [Related]
36. Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins Larkina M; Varvashenya R; Yuldasheva F; Plotnikov E; Bezverkhniaia E; Tretyakova M; Zelchan R; Schulga A; Konovalova E; Vorobyeva A; Belousov M; Orlova A; Tolmachev V; Deyev S Mol Pharm; 2024 Apr; 21(4):1919-1932. PubMed ID: 38557163 [TBL] [Abstract][Full Text] [Related]
37. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator. Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936 [TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging. Teng B; Bai Y; Chang Y; Chen S; Li Z Bioorg Med Chem Lett; 2007 Jun; 17(12):3440-4. PubMed ID: 17449246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]